Avera to enroll world’s first patients in new lung cancer trial
Avera will be the first in the world to enroll lung cancer patients in a clinical trial that is part of an international collaboration.
Avera will be the first in the world to enroll lung cancer patients in a clinical trial that is part of an international collaboration.